Analyst Consensus ?
ConsensusBuy33 ratings
Bullish2575.8%
Neutral824.2%
Bearish00.0%
FN2 Earnings Intelligence
MetLife, Inc. complete analyst coverage
MetLife, Inc. (MET) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$97.14Current
$68Low
$93.43Average
$145High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 11, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 22, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 9, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jun 24, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2024 |
| Argus Research | Buy | Buy | Maintain | May 22, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 9, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Raymond James | Perform | Market Perform | Maintain | Sep 22, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 22, 2022 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 19, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Mar 19, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jan 16, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Jul 16, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Jul 16, 2018 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Mar 26, 2018 |
| Argus | Buy | Buy | Maintain | Nov 6, 2017 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Feb 4, 2016 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 13, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jul 7, 2014 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 3, 2014 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $97.14. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Bob Huang | $111 | $95.75 | +14.3% | Aug 24, 2026 |
| Wells Fargo | Analyst unavailable | $109 | $96.73 | +12.2% | Aug 19, 2026 |
| Barclays | Analyst unavailable | $97 | $96.26 | -0.1% | Aug 6, 2026 |
| Atlantic Equities | Analyst unavailable | $103 | $92.44 | +6.0% | Jul 15, 2026 |
| Jefferies | Suneet Kamath | $103 | $91.15 | +6.0% | Jul 10, 2026 |
| UBS | Michael Ward | $105 | $90.27 | +8.1% | Jul 8, 2026 |
| Barclays | Alex Scott | $94 | $90.46 | -3.2% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $90.93 | +6.0% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $90 | $88.03 | -7.4% | Jun 24, 2026 |
| Piper Sandler | Analyst unavailable | $86 | $84.06 | -11.5% | May 26, 2026 |
| Morgan Stanley | Bob Huang | $93 | $83.5 | -4.3% | May 21, 2026 |
| Wells Fargo | Analyst unavailable | $95 | $77.98 | -2.2% | May 12, 2026 |
| Mizuho Securities | Yaron Kinar | $95 | $78.82 | -2.2% | May 8, 2026 |
| Barclays | Alex Scott | $93 | $80.16 | -4.3% | May 7, 2026 |
| Mizuho Securities | Yaron Kinar | $93 | $74.63 | -4.3% | Apr 13, 2026 |
| Evercore ISI | Analyst unavailable | $96 | $74.65 | -1.2% | Apr 9, 2026 |
| UBS | Analyst unavailable | $102 | $74.65 | +5.0% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $100 | $78.89 | +2.9% | Feb 12, 2026 |
| Evercore ISI | Thomas Gallagher | $95 | $77.92 | -2.2% | Feb 10, 2026 |
| UBS | Analyst unavailable | $98 | $78.01 | +0.9% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $102 | $77.08 | +5.0% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $97 | $78.32 | -0.1% | Jan 13, 2026 |
| UBS | Analyst unavailable | $94 | $79.79 | -3.2% | Jan 8, 2026 |
| Barclays | Analyst unavailable | $90 | $79.47 | -7.4% | Jan 8, 2026 |
| Evercore ISI | Analyst unavailable | $97 | $81.77 | -0.1% | Jan 6, 2026 |
| Mizuho Securities | Analyst unavailable | $101 | $82.62 | +4.0% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $101 | $83.22 | +4.0% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $98 | $82.75 | +0.9% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $97 | $82.7 | -0.1% | Oct 7, 2025 |
| Piper Sandler | John Barnidge | $84 | $79.07 | -13.5% | Sep 19, 2025 |
| Wolfe Research | Tracy Benguigui | $95 | $80.46 | -2.2% | Sep 15, 2025 |
| Morgan Stanley | Bob Huang | $98 | $77.74 | +0.9% | Jul 14, 2025 |
| Piper Sandler | John Barnidge | $94 | $82.49 | -3.2% | Apr 2, 2025 |
| Morgan Stanley | Analyst unavailable | $109 | $86.18 | +12.2% | Feb 28, 2025 |
| Piper Sandler | John Barnidge | $92 | $81.78 | -5.3% | Oct 2, 2024 |
| Barclays | Alex Scott | $91 | $77.52 | -6.3% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $96 | $76.85 | -1.2% | Aug 1, 2024 |
| Morgan Stanley | Bob Huang | $83 | $69.92 | -14.6% | Jul 10, 2024 |
| Argus Research | Kevin Heal | $80 | $73.15 | -17.6% | May 22, 2024 |
| Piper Sandler | John Barnidge | $82 | $70.94 | -15.6% | May 6, 2024 |
| CFRA | Catherine Seifert | $77 | $72.67 | -20.7% | Mar 13, 2024 |
| Goldman Sachs | Alex Scott | $80 | $68.92 | -17.6% | Jan 8, 2024 |
| Mizuho Securities | Brett Linzey | $145 | $63.79 | +49.3% | Sep 14, 2023 |
| Morgan Stanley | Analyst unavailable | $90 | $72.68 | -7.4% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $88 | $71.35 | -9.4% | Jan 10, 2023 |
| Goldman Sachs | Analyst unavailable | $78 | $73.58 | -19.7% | Jan 9, 2023 |
| J.P. Morgan | Analyst unavailable | $80 | $73.58 | -17.6% | Jan 6, 2023 |
| Jefferies | Analyst unavailable | $82 | $73.61 | -15.6% | Dec 9, 2022 |
| Morgan Stanley | Analyst unavailable | $87 | $74.01 | -10.4% | Nov 17, 2022 |
| Credit Suisse | Analyst unavailable | $77 | $67.39 | -20.7% | Aug 22, 2022 |
| Morgan Stanley | Analyst unavailable | $83 | $67.25 | -14.6% | Aug 17, 2022 |
| Morgan Stanley | Analyst unavailable | $79 | $64.14 | -18.7% | Aug 4, 2022 |
| Barclays | Analyst unavailable | $75 | $57.79 | -22.8% | Jul 14, 2022 |
| Evercore ISI | Analyst unavailable | $80 | $61.4 | -17.6% | Jul 6, 2022 |
| Morgan Stanley | Analyst unavailable | $78 | $61.58 | -19.7% | Jul 6, 2022 |
| Wolfe Research | Charles Lederer | $74 | $61.75 | -23.8% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $80 | $67.23 | -17.6% | May 5, 2022 |
| Evercore ISI | Thomas Gallagher | $75 | $64.18 | -22.8% | Jan 5, 2022 |
| Goldman Sachs | Alex Scott | $77 | $58.92 | -20.7% | Dec 2, 2021 |
| Credit Suisse | Andrew Kligerman | $68 | $63.12 | -30.0% | May 13, 2021 |
| Argus Research | Kevin Heal | $72 | $65.2 | -25.9% | May 7, 2021 |
Track every rating change on MET the moment it posts. Free to start.
Start free